INCREASE IN ANTI-5HT ACTIVITY BY 1-METHYLATION OF CLAVINE-TYPE ERGOT ALKALOIDS

被引：4
|
作者：
YUI, T
TAKEO, Y
机构：
来源：
JAPANESE JOURNAL OF PHARMACOLOGY | 1964年 / 14卷 / 01期
关键词：
D O I：
10.1254/jjp.14.107
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：107 / &
相关论文
共 50 条
  • [31] METHOTREXATE POTENTIATES ANTI-HERPES SIMPLEX VIRUS TYPE-1 ACTIVITY OF E-5-(2-BROMOVINYL)-2'-DEOXYURIDINE
    PANCHEVA, SN
    ACTA VIROLOGICA, 1995, 39 (02) : 117 - 119
  • [32] Anti-human immunodeficiency virus type 1 activity of R-95288, a phosphodiester hexadeoxyribonucleotide modified by dibenzyloxybenzyl and hydroxyethyl residues at the 5'- and 3'-ends
    Agatsuma, T
    Furukawa, H
    Hotoda, H
    Koizumi, M
    Koga, R
    Kaneko, M
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1997, 8 (05): : 429 - 438
  • [33] Wild type and H43Y variant of human TRIM5α show similar anti-human immunodeficiency virus type 1 activity both in vivo and in vitro
    Nakayama, Emi E.
    Carpentier, Wassila
    Costagliola, Dominique
    Shioda, Tatsuo
    Iwamoto, Aikichi
    Debre, Patrice
    Yoshimura, Kazuhisa
    Autran, Brigitte
    Matsushita, Shuzo
    Theodorou, Ioannis
    IMMUNOGENETICS, 2007, 59 (06) : 511 - 515
  • [34] Wild type and H43Y variant of human TRIM5α show similar anti-human immunodeficiency virus type 1 activity both in vivo and in vitro
    Emi E. Nakayama
    Wassila Carpentier
    Dominique Costagliola
    Tatsuo Shioda
    Aikichi Iwamoto
    Patrice Debre
    Kazuhisa Yoshimura
    Brigitte Autran
    Shuzo Matsushita
    Ioannis Theodorou
    Immunogenetics, 2007, 59 : 511 - 515
  • [35] STUDIES TO INCREASE THE ANTI-TUMOR ACTIVITY OF 1-(TETRAHYDRO-2-FURANYL)-5-FLUOROURACIL AND ITS METABOLIC ASPECTS BY COMBINED ADMINISTRATION WITH L-CYSTEINE
    KAWABATA, N
    SUGIYAMA, S
    KUWAMURA, T
    SATOH, T
    KITAGAWA, H
    JAPANESE JOURNAL OF PHARMACOLOGY, 1983, 33 (04): : 735 - 747
  • [36] 1,2,5-Benzothiadiazepine and pyrrolo[2,1-d][1,2,5]benzothiadiazepine derivatives with specific anti-human immunodeficiency virus type 1 activity
    Di Santo, R
    Costi, R
    Artico, M
    Massa, S
    Marongiu, ME
    Loi, AG
    De Montis, A
    La Colla, P
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1998, 9 (02): : 127 - 137
  • [37] 1,2,5-Benzothiadiazepine and pyrrolo[2,1-d][1,2,5]benzothiadiazepine derivatives with specific anti-human immunodeficiency virus type 1 activity
    Antiviral Chemistry & Chemotherapy, 9 (02):
  • [38] Structure-Based Design of PDZ Ligands as Inhibitors of 5-HT2A Receptor/PSD-95 PDZ1 Domain Interaction Possessing Anti-hyperalgesic Activity
    Vogrig, Alexandre
    Dorr, Liam
    Bouzidi, Naoual
    Boucherle, Benjamin
    Wattiez, Anne-Sophie
    Cassier, Elisabeth
    Vallon, Gary
    Ripoche, Isabelle
    Abrunhosa-Thomas, Isabelle
    Marin, Philippe
    Nauton, Lionel
    Thery, Vincent
    Courteix, Christine
    Lian, Lu-Yun
    Ducki, Sylvie
    ACS CHEMICAL BIOLOGY, 2013, 8 (10) : 2209 - 2216
  • [39] UCB 62045 - Pharmacology of a novel, dual-function anti-inflammatory agent with histamine type 1 receptor antagonist and 5-lipoxygenase inhibitor activity
    Selig, WM
    Bayless, L
    Libertine, L
    Eckman, JB
    Wypij, DM
    Wels, BF
    Eckert, M
    Young, MA
    Nicolas, JM
    Scannell, RT
    Ellis, JL
    CHEST, 2003, 123 (03) : 371S - 371S
  • [40] Synthesis and anti-influenza activity of 2-cyanoethoxy and 2-(1H-tetrazol-5-yl)ethoxy derivatives of dammarane-type triterpenoids
    A. D. Zorina
    A. S. Kaledina
    I. A. Motsepuro
    V. V. Anokhina
    S. A. Marchenko
    S. I. Selivanov
    V. V. Zarubaev
    R. E. Trifonov
    Russian Journal of Organic Chemistry, 2017, 53 : 1710 - 1716
12345